Home › Targets › VEGF-A

VEGF-A (4 companies · 9 programs)

Companies with an active program directed at VEGF-A.

Compass Therapeutics, Inc. CMPX

tovecimig — Biliary Tract Cancer Phase 2
tovecimib — Colorectal Cancer Phase 2
CTX-10726 Phase 1

Summit Therapeutics Inc. SMMT

ivonescimab — Non-Small Cell Lung Cancer NDA Submitted
ivonescimab — Colorectal Cancer Phase 3
ivonescimab — Head and Neck Squamous Cell Carcinoma Phase 3

4D Molecular Therapeutics, Inc. FDMT

4D-150 — Wet Age-Related Macular Degeneration Phase 3
4D-150 — Diabetic Macular Edema Phase 2

NovaBridge Biosciences NBP

VIS-101 — Wet Age-Related Macular Degeneration Phase 2